What is Bio-Rad Laboratories, Inc.'s europe — net sales?

Bio-Rad Laboratories, Inc. (BIO.B) reported europe — net sales of $206.8M in Q1 2026.

How has Bio-Rad Laboratories, Inc.'s europe — net sales changed year-over-year?

Bio-Rad Laboratories, Inc.'s europe — net sales increased by 3.5% year-over-year, from $199.8M to $206.8M.

What is the long-term trend for Bio-Rad Laboratories, Inc.'s europe — net sales?

Over 4 years (2021 to 2025), Bio-Rad Laboratories, Inc.'s europe — net sales has grown at a -1.8% compound annual growth rate (CAGR), from $947M to $881.8M.

Bio-Rad Laboratories, Inc. BIO.B Europe — Net Sales

Other geography segments

Asia Pacific

$110.4M+6.1%

Americas

$45.1M+13.3%

Similar metrics at other companies

AEurope — Net revenue

$518M+17.2%

EWEurope — Net Sales

$442.6M+29.5%

FLEXEurope — Net Sales

$1.42B+4.3%

SWKEurope — Net Sales

$820.9M+9.2%

COOEurope — Net Sales

$341.6M+17.0%

DAREurope — Net Sales

$487.72M+19.5%

Other financials

Income statement

See full

Revenue$592.1M+1.1%

Gross profit$309.4M+1.1%

Operating income$34.1M+43.9%

Net income-$527.1M-924%

EPS (diluted)-$19.55-954%

Balance sheet

See full

Cash & equivalents$509.0M-2.7%

Total debt$987.3M-28.4%

Total equity$6.9B+2.6%

Total assets$9.8B+2.8%

Cash flow

See full

Operating cash flow$108.1M-16.8%

CapEx$30.0M-12.8%

Free cash flow$78.1M-18.2%

Valuation

See full

Market cap$7.56B+10.3%

Enterprise value$8.04B+4.2%

P/E44.8×—

P/S2.9×+0.2×

Profitability

See full

Gross margin51.9%-1.6pp

Operating margin8.8%-3.1pp

Net margin6.5%+3.4pp

FCF margin13.8%-0.2pp

Returns & leverage

See full

Return on equity2.5%+1.3pp

Debt / equity0.1×-0.1×

Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Bio-Rad Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Rad Laboratories, Inc.'s europe — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bio-Rad Laboratories, Inc.'s europe — net sales?: Bio-Rad Laboratories, Inc. (BIO.B) reported europe — net sales of $206.8M in Q1 2026.
How has Bio-Rad Laboratories, Inc.'s europe — net sales changed year-over-year?: Bio-Rad Laboratories, Inc.'s europe — net sales increased by 3.5% year-over-year, from $199.8M to $206.8M.
What is the long-term trend for Bio-Rad Laboratories, Inc.'s europe — net sales?: Over 4 years (2021 to 2025), Bio-Rad Laboratories, Inc.'s europe — net sales has grown at a -1.8% compound annual growth rate (CAGR), from $947M to $881.8M.